Recent News

• 11.24.2025 - Employee Spotlight: Lily Lim
• 11.19.2025 - Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
• 11.13.2025 - Pregnant Woman, 27, Details Early Signs She Had a Life-Threatening Blood Clot: ‘I Was Shaking’
• 11.07.2025 - TCT 2025: STRIKE-PE Analyses Show CAVT Can Improve Functional Outcomes and Quality of Life for Intermediate- and High-Risk PE Patients
• 11.05.2025 - Penumbra, Inc. Reports Third Quarter 2025 Financial Results
• 11.03.2025 - Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
• 10.28.2025 - He Had to Fake a Heart Attack to Get the Care He Needed — Richard Davis’s Journey from Clotting Disorder to Patient Advocate
• 10.27.2025 - Penumbra takes TCT by STORM
• 10.27.2025 - Penumbra study backs mechanical thrombectomy for treating pulmonary embolism

Recent Filings

• 11.21.2025 - 144 Report of proposed sale of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.05.2025 - EX-99.1 EX-99.1
• 11.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.05.2025 - 8-K Current report